Working to preserve the health of women and families since 1995.

  • Jhpiego collaborated with the Ministry of Health (MOH) to introduce and expand postpartum IUD services, resulting in more than 300 health facilities across all 13 of the country’s regions now providing postpartum IUDs to women who recently delivered and want to space their next pregnancy.
  • From 2016 to 2018, the percentage of postpartum women adopting a family planning method increased from 25% to 55% and those who received postpartum family planning counseling increased from 46% to 77%—resulting in 47,837 women delaying their next pregnancy and 66,981 postpartum women counseled.
  • With the MOH, Jhpiego piloted and introduced cervical cancer prevention services at two university hospitals and subsequently expanded them to 12 additional sites with financial support from other organizations. From 2010 to 2014, 13,999 women were screened for cervical cancer, 8.9% screened positive and 65.9% of those who screened positive received cryotherapy in a single visit.
  • Jhpiego continues to provide expertise to the MOH’s malaria prevention, diagnosis and treatment activities, while building capacity of the National Malaria Control Program. In 2018, Jhpiego reached 441,902 children during the seasonal malaria chemoprevention campaign in 12 districts; in 2019, Jhpiego expanded the pre-transfer rectal artesunate intervention to two regions, treating 1,045 confirmed cases of severe malaria in children under five in May alone.

Our Work in Burkina Faso

Jhpiego is leading the five-year Improving Malaria Care project, funded by the U.S. Agency for International Development. The project provided technical assistance for the prevention, diagnosis and case management of malaria, with specific emphasis on malaria in pregnancy and in children under five, as well as on improving the National Malaria Control Program’s capacity. Through this project, Jhpiego aims to: 1) improve malaria prevention in support of the National Malaria Strategic Plan; 2) improve malaria diagnosis and treatment interventions in support of the National Malaria Strategic Plan; and 3) strengthen the National Malaria Control Program’s capacity to plan, design, manage and coordinate a comprehensive malaria control program. Under an additional award through this project, Jhpiego will provide technical assistance in infection prevention and control (IPC) to support the Ministry of Health to: 1) train frontline, public-sector health care workers on IPC; and 2) provide supportive supervision and coaching to improve IPC practices in health care services.

With funding from the U.S. Centers for Disease Control and Prevention, Jhpiego is supporting the prevention of antimicrobial resistance (AMR), an issue of increasing importance worldwide. The goal of the project is to improve local capacity to prevent, detect and effectively respond to infectious disease threats and prevent antimicrobial resistance. To reach this goal, Jhpiego is: 1) improving infection prevention and control at health facilities; 2) supporting development of a point prevalence of health care associated infections to strengthen referral and reporting systems across the health pyramid; and 3) supporting the tracking of antimicrobial use.

Under an initiative funded by a large anonymous donor, Jhpiego is strengthening pre-service education in Burkina Faso to increase the uptake of postpartum family planning (PPFP). This program aims to integrate PPFP into the pre-service education of midwives and obstetricians/gynecologists. Jhpiego is also providing innovative ways such as mobile mentoring (mMentoring) to keep new graduates and providers engaged with the information learned. Simultaneously, Jhpiego is also providing PPFP counseling and family planning methods to women.

This three-year project, funded by the Bill & Melinda Gates Foundation, seeks to uphold the quality of contraceptive implant services by working at the global and country levels. Globally, Jhpiego serves in a technical advisory role for the Implant Access Program’s Operations Group—a working group comprised of donor representatives that supports quality implant programs—to monitor, identify and collaboratively respond to priority issues. Jhpiego also provides short-term technical assistance to ensure that several countries with high implant use, including Burkina Faso, incorporate a quality implant removal component into overall implant strategy and implementation.

This four-year project, funded by the Bill & Melinda Gates Foundation, builds on the PMA2020 project, which used innovative mobile technology to support low-cost, rapid-turnaround surveys monitoring key health and development indicators. PMA is enhancing this survey platform to generate high-quality data and ensure that governments, donors, managers and advocates use this data to make decisions regarding family planning programs. In addition to scaling up the survey platform for more widespread use, this project supports expanding it to include additional technical areas. Co-led by Jhpiego and the Bill & Melinda Gates Institute for Population and Reproductive Health, this project is operational in several African and Asian countries, including Burkina Faso.

Funded by the Bill & Melinda Gates Foundation, this program promotes access to family planning choices in West African countries by supporting the introduction and scale-up of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC). DMPA-SC is an innovative injectable contraceptive—also known as Sayana® Press—that can dramatically expand access and choice for women. Jhpiego is enhancing ongoing efforts of the Access Collaborative by strengthening health systems to accelerate introduction and scale-up of DMPA-SC in several West African countries. This is being done in Burkina Faso through advocacy on the national, regional and local levels with officials, leaders, providers and clients, sharing of best practices among partners and the creation of a technical working group to work towards administration of DMPA-SC by community health workers and self-injection by patients.

Unitaid is funding a consortium, led by Expertise France, that seeks to eliminate cervical cancer in Burkina Faso, Côte d’Ivoire, Guatemala and the Philippines through secondary prevention (i.e., detecting disease early to slow or halt its progress). The three-year SUCCESS project is designed to shift the countries from a largely opportunistic cervical cancer screening model to a systematic approach centered on innovations related to: 1) reinforced and simplified cervical cancer screening through the introduction of human papilloma virus (HPV) testing with self-collection sampling; 2) secondary prevention of cervical cancer including use of efficient methods for treatment of cervical precancerous lesions such as thermal ablation; and 3) intensified dissemination of information on cervical cancer and new preventive technologies. In so doing, SUCCESS aims to support countries to “leapfrog” to a state-of-the-art services model recommended by the World Health Organization. As the implementing partner of the consortium, Jhpiego is integrating and expanding cervical cancer prevention and treatment services into both new and existing platforms, relying on our established relationships with governments and stakeholders in all four countries. Through demand-generation and community engagement activities, the project plans to screen a total of 185,000 women, a significant proportion of whom will be women living with HIV.

Under a sub-award with Plan International, funded by the European Commission, Jhpiego is helping to strengthen the supply and demand of civil and social promotion services at health center, community and school levels in two regions of Burkina Faso. Jhpiego is working closely with Plan International, the Ministry of Health, regional and district health teams and civil society organizations to help increase the supply and demand for family planning (FP) and other sexual and reproductive health services (SRH)—including services specific to youth and adolescents—at 160 health facilities and communities in the two regions. Jhpiego-led activities include: 1) support to the Ministry of Health to update FP policies and strategies; 2) capacity building of health care providers to provide a comprehensive FP package to couples and women of childbearing age, including adolescents and youth; 3) training of community health workers on community-based distribution of FP methods, including the injectable contraceptive DMPA-SC; 4) meetings with local leaders in each region by third-party nongovernmental organizations and local associations to advocate for the promotion of FP, adolescent SRH and children’s rights; and 5) provision of technical assistance to targeted governmental ministries and technical departments.

Country Contact

Stanislas Nebie, Country Director

Tel. 226 25 34 12 44

Boulevard Ratag Rima, Porte 1045

Quartier Gounghin sud, secteur 6

01 BP 5654 Ouagadougou 01

Burkina Faso

Current and Recent Donors

Bill & Melinda Gate Foundation

CDC

Clinton Health Access Initiative

European Commission

UNFPA

Unitaid

USAID